Carl Zeiss Medit-Unspon ADRCZMWY
13F holders, Q1 2026 (March 31)1holders
0new positions
0sold out
$28.25avg. 13F price*
At the end of Q1 2026, 1 institutions reported holding Carl Zeiss Medit-Unspon ADR (CZMWY) in their 13F filings, unchanged from Q4 2025. 0 opened new positions and 0 sold out. The largest holder was Rhumbline Advisers ($113).
- Company
- Carl Zeiss Medit-Unspon ADR
- CUSIP
- 14218T105
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q4 2025 → Q1 2026: 10 shares sold, net −10 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Rhumbline Advisers | 0.00% | Reduce -71.4% | 4 | $113 |
"% of holder's portfolio" is CZMWY's weight in each manager's 13F, not the share of Carl Zeiss Medit-Unspon ADR the manager owns.